MCKESSON CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that MCKESSON CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2010 | Mar 31, 2011 | $28.85B | May 5, 2011 |
| FY2010 | Dec 31, 2010 | $28.25B | May 5, 2011 |
| FY2010 | Sep 30, 2010 | $27.53B | May 5, 2011 |
| FY2010 | Jun 30, 2010 | $27.45B | May 5, 2011 |
| FY2010 | Mar 31, 2010 | $26.64B | May 5, 2011 |
| FY2010 | Dec 31, 2009 | $28.27B | May 5, 2011 |
| FY2010 | Sep 30, 2009 | $27.13B | May 5, 2011 |
| FY2010 | Jun 30, 2009 | $26.66B | May 5, 2011 |
| FY2009 | Mar 31, 2009 | $106.63B | May 4, 2010 |
| FY2009 | Mar 31, 2008 | $101.70B | May 4, 2010 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $359.05B | May 9, 2025 |
| FY2025 | Mar 31, 2024 | $308.95B | May 9, 2025 |
| FY2025 | Mar 31, 2023 | $276.71B | May 9, 2025 |
| FY2024 | Mar 31, 2022 | $263.97B | May 8, 2024 |
| FY2021 | Mar 31, 2021 | $59.14B | May 12, 2021 |
| FY2021 | Dec 31, 2020 | $62.60B | May 12, 2021 |
| FY2021 | Sep 30, 2020 | $60.81B | May 12, 2021 |
| FY2021 | Jun 30, 2020 | $55.68B | May 12, 2021 |
| FY2021 | Mar 31, 2020 | $58.54B | May 12, 2021 |
| FY2021 | Dec 31, 2019 | $59.17B | May 12, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Mar 31, 2018 | $51.63B | May 24, 2018 |
| FY2018 | Dec 31, 2017 | $53.62B | May 24, 2018 |
| FY2018 | Sep 30, 2017 | $52.06B | May 24, 2018 |
| FY2018 | Jun 30, 2017 | $51.05B | May 24, 2018 |
| FY2018 | Mar 31, 2017 | $48.71B | May 24, 2018 |
| FY2018 | Dec 31, 2016 | $50.13B | May 24, 2018 |
| FY2018 | Sep 30, 2016 | $49.96B | May 24, 2018 |
| FY2018 | Jun 30, 2016 | $49.73B | May 24, 2018 |
| FY2017 | Mar 31, 2016 | $46.68B | May 22, 2017 |
| FY2017 | Dec 31, 2015 | $47.90B | May 22, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $13.32B | May 9, 2025 |
| FY2025 | Mar 31, 2024 | $12.83B | May 9, 2025 |
| FY2025 | Mar 31, 2023 | $12.36B | May 9, 2025 |
| FY2024 | Mar 31, 2022 | $13.13B | May 8, 2024 |
| FY2021 | Mar 31, 2021 | $3.30B | May 12, 2021 |
| FY2021 | Dec 31, 2020 | $3.15B | May 12, 2021 |
| FY2021 | Sep 30, 2020 | $3.00B | May 12, 2021 |
| FY2021 | Jun 30, 2020 | $2.70B | May 12, 2021 |
| FY2021 | Mar 31, 2020 | $3.34B | May 12, 2021 |
| FY2021 | Dec 31, 2019 | $3.03B | May 12, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $3.30B | May 9, 2025 |
| FY2025 | Mar 31, 2024 | $3.00B | May 9, 2025 |
| FY2025 | Mar 31, 2023 | $3.56B | May 9, 2025 |
| FY2024 | Mar 31, 2022 | $1.11B | May 8, 2024 |
| FY2021 | Mar 31, 2021 | $666.00M | May 12, 2021 |
| FY2021 | Dec 31, 2020 | ($6.23B) | May 12, 2021 |
| FY2021 | Sep 30, 2020 | $577.00M | May 12, 2021 |
| FY2021 | Jun 30, 2020 | $444.00M | May 12, 2021 |
| FY2021 | Mar 31, 2020 | $1.02B | May 12, 2021 |
| FY2021 | Dec 31, 2019 | $186.00M | May 12, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $4.42B | May 9, 2025 |
| FY2025 | Mar 31, 2024 | $3.91B | May 9, 2025 |
| FY2025 | Mar 31, 2023 | $4.38B | May 9, 2025 |
| FY2024 | Mar 31, 2022 | $2.04B | May 8, 2024 |
| FY2023 | Mar 31, 2021 | ($5.04B) | May 9, 2023 |
| FY2022 | Mar 31, 2020 | $2.49B | May 9, 2022 |
| FY2021 | Mar 31, 2019 | $886.00M | May 12, 2021 |
| FY2020 | Mar 31, 2018 | $762.00M | May 22, 2020 |
| FY2019 | Mar 31, 2017 | $7.12B | May 15, 2019 |
| FY2018 | Mar 31, 2016 | $3.55B | May 24, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Mar 31, 2020 | $96.00M | May 22, 2020 |
| FY2020 | Mar 31, 2019 | $71.00M | May 22, 2020 |
| FY2020 | Mar 31, 2018 | $125.00M | May 22, 2020 |
| FY2019 | Mar 31, 2017 | $341.00M | May 15, 2019 |
| FY2018 | Mar 31, 2016 | $392.00M | May 24, 2018 |
| FY2017 | Mar 31, 2015 | $392.00M | May 22, 2017 |
| FY2016 | Mar 31, 2014 | $457.00M | May 5, 2016 |
| FY2015 | Mar 31, 2013 | $433.00M | May 12, 2015 |
| FY2013 | Mar 31, 2012 | $402.00M | May 14, 2014 |
| FY2012 | Mar 31, 2011 | $407.00M | May 7, 2013 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $8.51B | May 9, 2025 |
| FY2025 | Mar 31, 2024 | $8.66B | May 9, 2025 |
| FY2025 | Mar 31, 2023 | $7.78B | May 9, 2025 |
| FY2024 | Mar 31, 2022 | $10.54B | May 8, 2024 |
| FY2023 | Mar 31, 2021 | $8.85B | May 9, 2023 |
| FY2022 | Mar 31, 2020 | $9.18B | May 9, 2022 |
| FY2021 | Mar 31, 2019 | $8.44B | May 12, 2021 |
| FY2020 | Mar 31, 2018 | $8.14B | May 22, 2020 |
| FY2019 | Mar 31, 2017 | $7.45B | May 15, 2019 |
| FY2018 | Mar 31, 2016 | $7.38B | May 24, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $6.09B | May 9, 2025 |
| FY2025 | Mar 31, 2024 | $4.31B | May 9, 2025 |
| FY2025 | Mar 31, 2023 | $5.16B | May 9, 2025 |
| FY2024 | Mar 31, 2022 | $4.43B | May 8, 2024 |
| FY2023 | Mar 31, 2021 | $4.54B | May 9, 2023 |
| FY2022 | Mar 31, 2020 | $4.37B | May 9, 2022 |
| FY2021 | Mar 31, 2019 | $4.04B | May 12, 2021 |
| FY2020 | Mar 31, 2018 | $4.35B | May 22, 2020 |
| FY2019 | Mar 31, 2017 | $4.74B | May 15, 2019 |
| FY2018 | Mar 31, 2016 | $3.67B | May 24, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $537.00M | May 9, 2025 |
| FY2025 | Mar 31, 2024 | $431.00M | May 9, 2025 |
| FY2025 | Mar 31, 2023 | $390.00M | May 9, 2025 |
| FY2024 | Mar 31, 2022 | $388.00M | May 8, 2024 |
| FY2023 | Mar 31, 2021 | $451.00M | May 9, 2023 |
| FY2022 | Mar 31, 2020 | $362.00M | May 9, 2022 |
| FY2021 | Mar 31, 2019 | $426.00M | May 12, 2021 |
| FY2020 | Mar 31, 2018 | $405.00M | May 22, 2020 |
| FY2019 | Mar 31, 2017 | $404.00M | May 15, 2019 |
| FY2018 | Mar 31, 2016 | $488.00M | May 24, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $75.14B | May 9, 2025 |
| FY2025 | Mar 31, 2024 | $67.44B | May 9, 2025 |
| FY2024 | Mar 31, 2023 | $62.32B | May 8, 2024 |
| FY2023 | Mar 31, 2022 | $63.30B | May 9, 2023 |
| FY2022 | Mar 31, 2021 | $65.02B | May 9, 2022 |
| FY2021 | Mar 31, 2020 | $61.25B | May 12, 2021 |
| FY2020 | Mar 31, 2019 | $59.67B | May 22, 2020 |
| FY2019 | Mar 31, 2018 | $60.38B | May 15, 2019 |
| FY2018 | Mar 31, 2017 | $60.97B | May 24, 2018 |
| FY2017 | Mar 31, 2016 | $56.52B | May 22, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($2.07B) | May 9, 2025 |
| FY2025 | Mar 31, 2024 | ($1.97B) | May 9, 2025 |
| FY2024 | Mar 31, 2023 | ($1.86B) | May 8, 2024 |
| FY2023 | Mar 31, 2022 | ($2.27B) | May 9, 2023 |
| FY2022 | Mar 31, 2021 | ($21.00M) | May 9, 2022 |
| FY2021 | Mar 31, 2020 | $5.09B | May 12, 2021 |
| FY2020 | Mar 31, 2019 | $8.09B | May 22, 2020 |
| FY2019 | Mar 31, 2018 | $9.80B | May 15, 2019 |
| FY2018 | Mar 31, 2017 | $11.10B | May 24, 2018 |
| FY2017 | Mar 31, 2016 | $8.92B | May 22, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $10.02B | May 9, 2025 |
| FY2025 | Mar 31, 2024 | $10.13B | May 9, 2025 |
| FY2025 | Mar 31, 2023 | $9.95B | May 9, 2025 |
| FY2024 | Mar 31, 2022 | $9.45B | May 8, 2024 |
| FY2023 | Mar 31, 2021 | $9.49B | May 9, 2023 |
| FY2022 | Mar 31, 2020 | $9.36B | May 9, 2022 |
| FY2021 | Mar 31, 2019 | $9.36B | May 12, 2021 |
| FY2020 | Mar 31, 2018 | $10.92B | May 22, 2020 |
| FY2019 | Mar 31, 2017 | $10.59B | May 15, 2019 |
| FY2018 | Mar 31, 2016 | $9.79B | May 24, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $17.92B | May 9, 2025 |
| FY2025 | Mar 31, 2024 | $14.98B | May 9, 2025 |
| FY2024 | Mar 31, 2023 | $12.30B | May 8, 2024 |
| FY2023 | Mar 31, 2022 | $9.03B | May 9, 2023 |
| FY2022 | Mar 31, 2021 | $8.20B | May 9, 2022 |
| FY2021 | Mar 31, 2020 | $13.02B | May 12, 2021 |
| FY2020 | Mar 31, 2019 | $12.41B | May 22, 2020 |
| FY2019 | Mar 31, 2018 | $12.99B | May 15, 2019 |
| FY2018 | Mar 31, 2017 | $13.19B | May 24, 2018 |
| FY2017 | Mar 31, 2016 | $8.36B | May 22, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $5.69B | May 9, 2025 |
| FY2025 | Mar 31, 2024 | $4.58B | May 9, 2025 |
| FY2025 | Mar 31, 2023 | $4.68B | May 9, 2025 |
| FY2024 | Mar 31, 2022 | $3.53B | May 8, 2024 |
| FY2023 | Mar 31, 2021 | $6.28B | May 9, 2023 |
| FY2022 | Mar 31, 2020 | $4.02B | May 9, 2022 |
| FY2021 | Mar 31, 2019 | $2.98B | May 12, 2021 |
| FY2019 | Mar 31, 2018 | $2.67B | May 15, 2019 |
| FY2018 | Mar 31, 2017 | $2.78B | May 24, 2018 |
| FY2018 | Mar 31, 2016 | $4.05B | May 24, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $5.65B | May 9, 2025 |
| FY2025 | Mar 31, 2024 | $5.63B | May 9, 2025 |
| FY2024 | Mar 31, 2023 | $5.59B | May 8, 2024 |
| FY2023 | Mar 31, 2022 | $5.88B | May 9, 2023 |
| FY2022 | Mar 31, 2021 | $7.15B | May 9, 2022 |
| FY2021 | Mar 31, 2020 | $7.39B | May 12, 2021 |
| FY2020 | Mar 31, 2019 | $7.60B | May 22, 2020 |
| FY2019 | Mar 31, 2018 | $7.88B | May 15, 2019 |
| FY2018 | Mar 31, 2017 | $8.36B | May 24, 2018 |
| FY2017 | Mar 31, 2016 | $8.11B | May 22, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 25 | May 9, 2025 |
| FY2025 | Mar 31, 2024 | 22 | May 9, 2025 |
| FY2025 | Mar 31, 2023 | 25 | May 9, 2025 |
| FY2024 | Mar 31, 2022 | 7 | May 8, 2024 |
| FY2021 | Mar 31, 2021 | 4 | May 12, 2021 |
| FY2021 | Dec 31, 2020 | (39) | May 12, 2021 |
| FY2021 | Sep 30, 2020 | 3 | May 12, 2021 |
| FY2021 | Jun 30, 2020 | 2 | May 12, 2021 |
| FY2021 | Mar 31, 2020 | 5 | May 12, 2021 |
| FY2021 | Dec 31, 2019 | 1 | May 12, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 25 | May 9, 2025 |
| FY2025 | Mar 31, 2024 | 22 | May 9, 2025 |
| FY2025 | Mar 31, 2023 | 25 | May 9, 2025 |
| FY2024 | Mar 31, 2022 | 7 | May 8, 2024 |
| FY2021 | Mar 31, 2021 | 4 | May 12, 2021 |
| FY2021 | Dec 31, 2020 | (39) | May 12, 2021 |
| FY2021 | Sep 30, 2020 | 3 | May 12, 2021 |
| FY2021 | Jun 30, 2020 | 2 | May 12, 2021 |
| FY2021 | Mar 31, 2020 | 5 | May 12, 2021 |
| FY2021 | Dec 31, 2019 | 1 | May 12, 2021 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $345.00M | May 9, 2025 |
| FY2025 | Mar 31, 2024 | $314.00M | May 9, 2025 |
| FY2025 | Mar 31, 2023 | $292.00M | May 9, 2025 |
| FY2024 | Mar 31, 2022 | $277.00M | May 8, 2024 |
| FY2023 | Mar 31, 2021 | $276.00M | May 9, 2023 |
| FY2022 | Mar 31, 2020 | $294.00M | May 9, 2022 |
| FY2021 | Mar 31, 2019 | $292.00M | May 12, 2021 |
| FY2020 | Mar 31, 2018 | $262.00M | May 22, 2020 |
| FY2019 | Mar 31, 2017 | $253.00M | May 15, 2019 |
| FY2018 | Mar 31, 2016 | $244.00M | May 24, 2018 |